Columbia University has granted a new licence to its cardiovascular research platform spinout Tara Biosystems, which markets services powered by is "heart-on-a-chip" tissue modelling system.
Columbia University on Tuesday awarded an additional licence to US-based Tara Biosystems, a cardiovascular research spinout of the institution, to advance intellectual property related to engineered human heart tissues.
Founded in 2014, Tara Biosystems provides research services and assays for drug programs targeting heart conditions. The services rely on a “heart-on-a-chip” tissue modelling technology, marketed as Biowire II, that is able to produce engineered heart tissues for uses including drug discovery and cardiac risk profiling.
The latest…
